Back
Lixte Biotechnology Holdings Quote, Financials, Valuation and Earnings
Sponsored
LIXT
Sponsored
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.
Sell
18
LIXT
Lixte Biotechnology Holdings
Last Price:
1.69
Seasonality Move:
2.1%
7 Day Trial
ALL ACCESS PASS
$
7
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.Lixte Biotechnology Holdings Price Quote
$1.69
+0.07 (+5.63%)
(Updated: November 16, 2024 at 5:26 AM ET)
Lixte Biotechnology Holdings Key Stats
Sell
18
Lixte Biotechnology Holdings (LIXT)
is a Sell
Day range:
$1.59 - $1.73
52-week range:
$1.31 - $4.42
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
15.5K
Avg. volume:
1.2M
1-year change:
-44.14%
Market cap:
$3.6M
Revenue:
$0
EPS:
$-1.78
How Much Does Lixte Biotechnology Holdings Make?
Data Unavailable
Is Lixte Biotechnology Holdings Growing As A Company?
Data Unavailable
Lixte Biotechnology Holdings Stock Price Performance
-
Did Lixte Biotechnology Holdings Stock Go Up Last Month?
Lixte Biotechnology Holdings share price went down by -10% last month -
Did LIXT's Share Price Rise Over The Last Year?
LIXT share price fell by -44.14% over the past 1 year
What Is Lixte Biotechnology Holdings 52-Week High & Low?
-
What Is Lixte Biotechnology Holdings’s 52-Week High Share Price?
Lixte Biotechnology Holdings has traded as high as $4.42 over the past 52 weeks -
What Is Lixte Biotechnology Holdings’s 52-Week Low Share Price?
Lixte Biotechnology Holdings has traded as low as $1.31 over the past 52 weeks
Lixte Biotechnology Holdings Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Lixte Biotechnology Holdings?
-
How Much Debt Does Lixte Biotechnology Holdings Have?
Total long term debt quarterly is $0 -
How Much Cash Does Lixte Biotechnology Holdings Have?
Cash and short term investments quarterly total is $2.6M -
What Is Lixte Biotechnology Holdings’s Book Value Per Share?
Book value per share is -0.56
Is Lixte Biotechnology Holdings Cash Flow Positive?
-
What Is LIXT Cash Flow From Operations?
Cash flow from operations (TTM) is -$3.5M -
What Is Lixte Biotechnology Holdings’s Cash Flow From Financing?
Cash flow from financing (TTM) is $3.1M -
What Is Lixte Biotechnology Holdings’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Lixte Biotechnology Holdings Return On Invested Capital
Data Unavailable
Lixte Biotechnology Holdings Earnings Date & Stock Price
-
What Is Lixte Biotechnology Holdings's Stock Price Today?
A single share of LIXT can be purchased today for 1.62 -
What Is Lixte Biotechnology Holdings’s Stock Symbol?
Lixte Biotechnology Holdings trades on the nasdaq under the ticker symbol: LIXT -
When Is Lixte Biotechnology Holdings’s Next Earnings Date?
The next quarterly earnings date for Lixte Biotechnology Holdings is scheduled on May 9, 2025 -
When Is LIXT's next ex-dividend date?
Lixte Biotechnology Holdings's next ex-dividend date is November 17, 2024 -
How To Buy Lixte Biotechnology Holdings Stock?
You can buy Lixte Biotechnology Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Lixte Biotechnology Holdings Competitors
-
Who Are Lixte Biotechnology Holdings's Competitors?
Below is a list of companies who compete with Lixte Biotechnology Holdings or are related in some way:
Lixte Biotechnology Holdings Dividend Yield
-
What Is LIXT Dividend Yield?
Lixte Biotechnology Holdings’s dividend yield currently is 0% -
What Is Lixte Biotechnology Holdings’s Payout Ratio?
Lixte Biotechnology Holdings’s payout ratio is 0% -
When Did Lixte Biotechnology Holdings Last Pay A Dividend?
The latest dividend pay date is November 17, 2024 -
What Is Lixte Biotechnology Holdings’s Dividend Per Share?
Lixte Biotechnology Holdings pays a dividend of $0.00 per share
Lixte Biotechnology Holdings Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 0.00 |
Downside from Last Price: | -100% |